QXDX
LIVE

Serial Number

90775545

Owner

BIO-RAD LABORATORIES, INC.

Attorney

Margaret C. McHugh

Filing Date

Jun 15, 2021

Add to watchlist:

No watchlists yet
View on USPTO

QXDX Trademark

Serial Number: 90775545 • Registration: 7139941

QXDX is a trademark filed by BIO-RAD LABORATORIES, INC. on June 15, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

BIO-RAD LABORATORIES, INC. (237 trademarks)

HERCULES, CA 94547

Entity Type: 03

Trademark Details

Filing Date

June 15, 2021

Registration Date

August 15, 2023

Published for Opposition

October 4, 2022

Goods & Services

Apparatus, namely, medical laboratory research instruments and scientific laboratory research instruments for preparation, handling, amplification, and analysis of samples containing nucleic acids; accessories in the nature of laboratory apparatus, namely, sample preparation containers and kits consisting primarily of sample preparation containers and reagents, and instruction manuals sold as a unit therewith, used to prepare laboratory samples for use in scientific and medical research, all in connection with the preparation, handling, amplification, and analysis of samples containing nucleic acids; scientific apparatus, instruments and equipment for scientific research, non-medical diagnostic analysis, chemical analysis, clinical analysis and industrial use, namely, DNA and RNA testing apparatus; scientific laboratory equipment and apparatus, namely, digital polymerase chain reaction (dPCR) apparatus, electrophoresis apparatus, gel electrophoresis apparatus, and thermal cyclers, for use in amplifying, labeling, and analyzing nucleic acids, and parts and consumable parts therefor, namely, tubes, plates, cartridges, holders, and containers for liquids and gels; Laboratory apparatus and instruments, namely, digital Polymerase Chain Reaction (dPCR) instruments for amplifying DNA using digital Polymerase Chain Reaction (dPCR) for use in scientific research; Scientific apparatus and instruments, namely, droplet generators for sample preparation of nucleic acids and droplet reader for amplifying and analyzing samples containing nucleic acids; Downloadable and recorded software for use in for operation and maintenance of scientific apparatus, instruments and equipment, namely, operating quantitative Polymerase Chain Reaction (PCR) instruments; Polymerase Chain Reaction (PCR) instruments for use in scientific research, namely, laboratory apparatus and instruments for amplifying DNA using Polymerase Chain Reaction (PCR); downloadable computer software for use in amplifying, labeling, and analyzing nucleic acids; computer hardware and downloadable and integrated software for use in gene analysis); Downloadable and recorded computer software and hardware for processing diagnostic medical testing or laboratory data; Downloadable and recorded computer software and hardware for data analysis for use in laboratories; Downloadable and recorded computer software for operation and maintenance of scientific apparatus, instruments and equipment; Clinical medical laboratory apparatus and analytical instruments, namely, digital Polymerase Chain Reaction (dPCR) instruments for use in-vitro and in-vivo diagnostics

Diagnostic preparations for medical purposes; Diagnostic preparations for medical purposes, namely, reagents, enzymes, oligonucleotides, and buffer solutions for amplifying, labeling, and analyzing biopolymers and nucleic acids for diagnostic medical use and clinical use; Chemical reagents for medical or veterinary purposes; Chemical, biochemical and biotechnological preparations for medical and veterinary purposes, in particular reagents, enzymes and buffer solutions for marking, amplifying, quantification and/or for the analysis of biopolymers, in particular nucleic acids, in particular reagents, enzymes and buffer solutions for nucleic acid amplification; Medical diagnostic reagent kits comprised of clinical medical reagents and assays for clinical and medical use; Diagnostic test kits comprised of medical diagnostic reagents and assays for testing in the field of medical diagnostics; Kits comprising chemicals, reagents, enzymes, and buffer solutions for amplifying and labeling nucleic acids for diagnostic medical use and clinical use; Chemical test kits for cell assays for medical and veterinary use; Cartridges containing medical diagnostic reagents for use in Polymerase Chain Reaction (PCR) and digital Polymerase Chain Reaction (dPCR)

Chemical reagents for scientific and medical research purposes; diagnostic reagents for clinical or medical laboratory use; Polymerase Chain Reaction (PCR) and digital Polymerase Chain Reaction (dPCR) reagents for scientific and medical research purposes; reagents for amplification and detection of nucleic acids for scientific and medical research purposes; Kits comprising chemicals, reagents, enzymes, and buffer solutions for amplifying and labeling nucleic acids for scientific and research use; Reagent kits comprising biological protein, DNA primers, polymerase or buffers for scientific and medical research use; Kits comprising chemicals, reagents, enzymes, and buffer solutions for amplifying and labeling nucleic acids for scientific or research use; Kits consisting primarily of reagents and magnetic, polymeric, or gel beads for scientific research use purposes

Apparatus, namely, DNA and RNA testing apparatus for medical and veterinary diagnostic analysis and determination of medical and veterinary conditions; Medical diagnostic apparatus and instruments, namely, Polymerase Chain Reaction (PCR) instrument to perform amplification and analyzation of nucleic acids; Medical devices and instruments, namely, a digital Polymerase Chain Reaction (dPCR) platform for use in measuring and quantifying copy number of DNA for medical diagnostic purposes; Medical devices and instruments, namely, a digital Polymerase Chain Reaction (dPCR) platform for use in measuring and quantifying copy number of DNA for medical diagnostic purposes; Diagnostic kits consisting primarily of electronic medical instruments for medical diagnosis and analysis of body fluids, tissues, biomolecules, DNA, antibodies, proteins, molecular material or cellular material

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 15, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 15, 2023 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jul 14, 2023 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jul 13, 2023 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Jun 20, 2023 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jun 20, 2023 AITU
USE AMENDMENT FILED
May 26, 2023 IUAF
TEAS STATEMENT OF USE RECEIVED
May 26, 2023 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 29, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 4, 2022 NPUB
PUBLISHED FOR OPPOSITION
Oct 4, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 14, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 26, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 29, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 29, 2022 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jul 29, 2022 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Apr 28, 2022 GNFN
FINAL REFUSAL E-MAILED
Apr 28, 2022 GNFR
FINAL REFUSAL WRITTEN
Apr 28, 2022 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 14, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 13, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 13, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 4, 2021 GNRN
NON-FINAL ACTION E-MAILED
Nov 4, 2021 GNRT
NON-FINAL ACTION WRITTEN
Nov 4, 2021 CNRT
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 20, 2021 GNRN
NON-FINAL ACTION E-MAILED
Sep 20, 2021 GNRT
NON-FINAL ACTION WRITTEN
Sep 20, 2021 CNRT
ASSIGNED TO EXAMINER
Sep 20, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 2, 2021 NWOS
NEW APPLICATION ENTERED
Jun 18, 2021 NWAP